Navigating Key Complexities in the Development of Cell and Gene Therapies 

Cell and gene therapies are unique and relatively untested drugs. Typically, the public may not reap the therapy’s benefits for years since each therapy is tailored to an individual’s genome. Paired with market volatility and operational challenges, biotech organizations are always facing navigational challenges as they bring these therapies to market.